Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Internal Discourses and Perception of Trail-running Effort (UT4M2022)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05389111
Recruitment Status : Not yet recruiting
First Posted : May 24, 2022
Last Update Posted : May 24, 2022
Sponsor:
Information provided by (Responsible Party):
University Hospital, Grenoble

Brief Summary:
Determination of the effect of an intervention to develop the use of internal discourses on the perception of exercise during a sub-maximum effort following a trail running

Condition or disease Intervention/treatment Phase
Physical Exertion Other: Internal discourses Other: Non internal discourses Not Applicable

Detailed Description:

The practice of mountain running or "trail" is in full development in France and elsewhere in the world. This sport practice is associated with various constraints specific to the activity.

These constraints imposed on the body during the preparation, participation and recovery of this type of effort have an impact on multiple aspects of the individual (physiological, psychological, neurological...). Some studies have made it possible in each of the fields to advance the current knowledge about the trail-running environment. However, there are very few links between variables from different fields of research, even though these links are at the origin of the complex individual responses observed in the field.

Therefore it seems important to study the practice of trail running and its consequences on the individual, relying on a systemic approach of the individual who studies how psychological phenomena, physiological and cerebral interactions to predict behaviour and its health consequences.

The biopsychosocial models are based on this systemic approach and postulate that the perception of the individual's effort would be the main limit to the continuity of effort, performance because it causes the intensity to decrease - or even stop the effort - if this sensation becomes too strong.

Consequently, the study of certain interventions aimed at reducing this perception of effort, such as the one proposed in this project, seems to be an essential step to propose to the practitioners of this type of sport strategies allowing to practice in a healthy and efficient way.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 180 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Other
Official Title: The Effect of Internal Discourses on the Perception of Trail-running Effort
Estimated Study Start Date : May 2022
Estimated Primary Completion Date : October 2023
Estimated Study Completion Date : November 2023

Arm Intervention/treatment
Experimental: Internal discourses
Introduction to internal discourses with a brief definition and key elements for implementation.
Other: Internal discourses
This intervention will take place following the randomization performed at the V1 visit. It will be held in videoconference, will be led by a professional of the training field, specialist of the trail activity and trained in the use of mental strategies

Sham Comparator: Non-internal discourses
Introduction to the risks associated with the practice of activity in the mountain environment and practical tips to prevent the risks
Other: Non internal discourses
This intervention will take place following the randomization performed at the V1 visit. It will be held in videoconference, and will be conducted by a professional of the training field, specialist of the trail activity and coach of mountain guide




Primary Outcome Measures :
  1. Perception of effort during running. [ Time Frame: 1 day ]
    Perception of Borg scale rated effort (0 no effort; 10, maximal effort) while running on a treadmill at sub-maximum intensity


Secondary Outcome Measures :
  1. Psychological profiles of trail-running practitioners [ Time Frame: 18 months ]
    Assessement of internal discourses use, pre-competitive anxiety, self-determined motivation to practice, achievement goals assessed by a questionnaire

  2. Perception of effort depending on running distance [ Time Frame: 18 months ]
    Comparison of the perception of effort (Borg scale rated effort (0 no effort; 10, maximal effort) while running) between subjects according to the distance of running

  3. Link between the individual's physical level and perception of effort [ Time Frame: 18 months ]
    Correlation between VO2max assessed during exercise testing in the laboratory and effort perception

  4. Serological library [ Time Frame: 18 months ]
    Comparison of circulating markers (e.g. BDNF, s100, creatine kinase, interleukins, to be defined a posteriori according to the physiological and cerebral effects observed) before and after the race

  5. Performance on a cognitive task [ Time Frame: 3 months ]
    Performance on a cognitive task performed on a computer

  6. Brain activation during a cognitive task [ Time Frame: 3 months ]
    Changes in brain oxygenation assessed by NIRS during a cognitive task

  7. Perception of effort, attentional focus, self-efficacy and resources of self-control during a race situation [ Time Frame: 1 day ]
    Change in perception of effort, attentional focus, self-efficacy and self-monitoring resources, assessed by a questionnaire during the race

  8. Recovery kinetics of runners after a trail race. [ Time Frame: 2 weeks ]
    Changes in the previous outcomes will be evaluated between the end of the race and 1-2 weeks after the race



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male or female
  • 18-55 years
  • Subjects available in Grenoble before and during the 15 days after the race
  • Subjects subject to a social security scheme
  • Subjects able to sign informed consent.
  • Fluent in French

Exclusion Criteria:

  • Cardiorespiratory, metabolic and neurological conditions
  • People treated with anxiolytics and/or neuroleptics or ATCD for behavioural disorders
  • Persons refusing to sign the participation consent
  • Persons under guardianship
  • Persons referred to in Articles L1121-5 to L1121-8 of the CSP

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05389111


Locations
Layout table for location information
France
CHU Grenoble Alpes
Grenoble, France, 38043
Contact: Stéphane DOUTRELEAU, Phd    +33476765494    SDoutreleau@chu-grenoble.fr   
Contact: Natacha GOSSET    +33476768108    NGosset@chu-grenoble.fr   
Principal Investigator: Stéphane DOUTRELEAU, Phd         
Sponsors and Collaborators
University Hospital, Grenoble
Layout table for additonal information
Responsible Party: University Hospital, Grenoble
ClinicalTrials.gov Identifier: NCT05389111    
Other Study ID Numbers: 38RC22.0111
First Posted: May 24, 2022    Key Record Dates
Last Update Posted: May 24, 2022
Last Verified: May 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No